• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT STAT HIGH SENSITIVE TROPONIN-I; IMMUNOASSAY METHOD, TROPONIN SUBUNIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT STAT HIGH SENSITIVE TROPONIN-I; IMMUNOASSAY METHOD, TROPONIN SUBUNIT Back to Search Results
Catalog Number 03P25-27
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/09/2023
Event Type  malfunction  
Event Description
The customer observed falsely depressed architect stat high sensitive troponin-i results generated for a 74-year-old male patient, who had chest pain on (b)(6) 2023.The patient has a history of heart failure, and current medication list includes stagid, eliquis, valsartan, and risperidone.The following data was provided ( customer¿s reference range for architect >5 pg/ml is positive.Customer¿s reference range for i-stat >30 pg/ml is positive): (b)(6) 2023 sample id (b)(6)initial results = <5 pg/ml, repeat result on i-stat = 170 pg/ml.(b)(6) 2023 same sample repeated on architect; result = 5-6 pg/ml, repeat on i-stat = 40 pg/ml.Same patient new sample obtained on (b)(6) 2023: sample id (b)(6) initial result = 6 pg/ml, repeat result on i-stat = 83 pg/ml.No impact to patient management was reported.
 
Manufacturer Narrative
This report is being filed on an international product, list number 3p25, that has a similar product distributed in the us, list number 2r98.An evaluation is in process.A final report will be submitted when the evaluation is complete.Completed information for section a1 patient identification: sids (b)(6) and (b)(6) all available patient information was included.Additional patient details are not available.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and field data review.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue.Ticket search by lot indicates that the reagent lot performs as expected.Ticket trending review did not identify any trends.Device history record review did not identify any non-conformances, potential non-conformances, or deviations with the complaint lot.Customer field data was used to assess the performance of the architect stat high sensitive troponin-i assay using worldwide data.Review shows that the median patient result for lot 53407ud00 is within established limits and comparable with other lots in the field, confirming no systemic issue for the lot.Labeling was reviewed which adequately addresses the current issue.Based on the investigation, no systemic issue or deficiency with the architect stat high sensitive troponin-i reagent kit, lot number 53407ud00, was identified.
 
Event Description
The customer observed falsely depressed architect stat high sensitive troponin-i results generated for a 74-year-old male patient, who had chest pain on 09sep2023.The patient has a history of heart failure, and current medication list includes stagid, eliquis, valsartan, and risperidone.The following data was provided ( customer¿s reference range for architect >5 pg/ml is positive.Customer¿s reference range for i-stat >30 pg/ml is positive): 09sep2023 sample id (b)(6) initial results = <5 pg/ml, repeat result on i-stat = 170 pg/ml 10sep2023 same sample repeated on architect; result = 5-6 pg/ml, repeat on i-stat = 40 pg/ml (b)(6) initial result = 6 pg/ml, repeat result on i-stat = 83 pg/ml no impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT STAT HIGH SENSITIVE TROPONIN-I
Type of Device
IMMUNOASSAY METHOD, TROPONIN SUBUNIT
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key17857248
MDR Text Key325088582
Report Number3005094123-2023-00265
Device Sequence Number1
Product Code MMI
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K191595
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/06/2023
Device Catalogue Number03P25-27
Device Lot Number53407UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/12/2023
Initial Date FDA Received10/02/2023
Supplement Dates Manufacturer Received10/05/2023
Supplement Dates FDA Received10/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/22/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I1000SR INTGR, 01L86-40, I1SR61096; ARC I1000SR INTGR, 01L86-40, I1SR61096
Patient Age74 YR
Patient SexMale
-
-